Related Experiment Videos

[Bacteroides fragilis meningitis. 2 cases]

Presse Medicale (Paris, France : 1983)
|October 4, 1986
PubMed

Insights

Bacteroides fragilis meningitis primarily affects the very young or elderly, often linked to contributing factors. Nitro-imidazole derivatives are the recommended treatment due to their effectiveness and cerebrospinal fluid penetration.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Microbiology

Background:

  • Review of clinical and therapeutic features of meningitis caused by Bacteroides fragilis.
  • Analysis based on 2 personal cases and 23 literature cases.

Observation:

  • Bacteroides fragilis meningitis predominantly affects the very young or elderly.
  • Contributing factors are present in 54% of cases.
  • Clinical presentation includes infectious syndrome, meningoencephalitis, and motor disorders.

Findings:

  • Septicemia occurs in 80% of cases, yet general condition is moderately affected.
  • Elevated blood leucocyte counts and typical bacterial meningitis CSF disturbances are observed.
  • Initial infection focus identified in 60% of cases.
  • Higher mortality rates in adults compared to children.
  • Frequent neurological complications are noted.

Implications:

  • Nitro-imidazole derivatives are the treatment of choice for Bacteroides fragilis meningitis.
  • High cerebrospinal fluid concentrations of nitro-imidazoles are crucial for effective treatment.
  • Understanding risk factors and clinical presentation aids in early diagnosis and management.

Related Concept Videos